Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Biodegradable and biocompatible subcutaneous implants consisted of pH-sensitive mebendazole-loaded/folic acid-targeted chitosan nanoparticles for murine triple-negative breast cancer treatment

Fig. 6

a Subcutaneous implantation of the CS-FA-MBZ implants. A small incision was made at the left flank of mice and the implant was placed inside it. The incision was sutured. The implantation site on the 18th day after cancer cells injection (15th day after surgery). b Tumors’ growth progression in different groups including Control, MBZ, CS-FA, and CS-FA-MBZ from the 3rd to 18th day after cancer cells injection (not significant: ns, *: P < 0.05). c Harvested skin of the implants-bearing mice at the 3rd and 15th days after implantation which equates the 6th and 18th days after cancer cells injection, respectively

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us